Scynexis, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Scynexis, Inc..The latest application filed is for "antifungal agents for candida auris decolonization".

Company Profile

10.20.25

Scynexis, Inc. - Jersey City NJ US
SCYNEXIS, INC. - Research Triangle Park NC
Avista Pharma Solutions, Inc. d/b/a Scynexis, Inc. - Durham NC US
Scynexis, Inc. - Durham NC
Scynexis, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Antifungal Agents For Candida Auris Decolonization App 20220211684 - Angulo Gonzalez; David A. ; et al.	2022-07-07
Antifungal Agents Used In Combination App 20220202833 - Angulo Gonzalez; David A.	2022-06-30
Triterpenoid Antifungals For The Treatment Of Fungal Osteo-articular Infections App 20220117948 - Angulo Gonzalez; David A.	2022-04-21
Novel Salts And Polymorphs Of Scy-078 App 20210395296 - ZHANG; YI	2021-12-23
Antifungal agents used in combination Grant 11,110,102 - Angulo Gonzalez September 7, 2	2021-09-07
Salts and polymorphs of SCY-078 Grant 10,927,142 - Zhang February 23, 2	2021-02-23
Antifungal Agents With Enhanced Activity In Acidic Ph App 20200390751 - ANGULO GONZALEZ; David A.	2020-12-17
Injectable Compositions Of Triterpenoid Antifungals Encapsulated In Liposomes App 20200338002 - Motheram; Rajeshwar	2020-10-29
Novel Salts And Polymorphs Of Scy-078 App 20190359648 - ZHANG; Yi	2019-11-28
Salts and polymorphs of SCY-078 Grant 10,370,406 - Zhang	2019-08-06
Novel Salts And Polymorphs Of Scy-078 App 20190153024 - ZHANG; Yi	2019-05-23
Salts and polymorphs of SCY-078 Grant 10,174,074 - Zhang J	2019-01-08
Antifungal Agents Used In Combination App 20180325919 - Angulo Gonzalez; David A.	2018-11-15
Antiparasitic Compounds App 20160280700 - LIU; Hao ; et al.	2016-09-29
Novel Salts And Polymorphs Of Scy-078 App 20160207956 - Zhang; Yi	2016-07-21
Macrocyclic peptides Grant 9,090,671 - Li , et al. July 28, 2	2015-07-28
Antiviral Macrocycles App 20140213508 - Li; Keqiang ; et al.	2014-07-31
Macrocycles App 20140212381 - Li; Keqiang ; et al.	2014-07-31
Processes for isolation and purification of enfumafungin Grant 8,674,087 - Pollard , et al. March 18, 2	2014-03-18
Methods for the treatment and prevention of ocular disorders Grant 8,551,952 - Houck October 8, 2	2013-10-08
Macrocycles Grant 8,536,114 - Li , et al. September 17, 2	2013-09-17
Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection Grant 8,329,658 - Houck , et al. December 11, 2	2012-12-11
3-ether And 3-thioether Substituted Cyclosporin Derivatives For The Treatment And Prevention Of Hepatitis C Infection App 20120264679 - Fliri; Hans Georg ; et al.	2012-10-18
Genetic Markers Associated With Response To Cyclophilin-binding Compounds App 20120208746 - HOPKINS; Samuel Earl ; et al.	2012-08-16
Antifungal agents Grant 8,222,255 - Balkovec , et al. July 17, 2	2012-07-17
Method for the treatment and prevention of ocular disorders Grant 8,188,052 - Houck May 29, 2	2012-05-29
Novel Cyclosporin Analogues App 20120010131 - Ogbu; Cyprian Okwara ; et al.	2012-01-12
Novel Cyclic Peptides App 20110144005 - Li; Keqiang ; et al.	2011-06-16
Antifungal agents Grant 7,863,465 - Balkovec , et al. January 4, 2	2011-01-04
Pharmaceutical Compositions App 20100227801 - HOPKINS; Samuel Earl	2010-09-09
Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection Grant 7,754,685 - Houck July 13, 2	2010-07-13
Dosing Forms And Regimens Comprising 3-[(r)-2-(n,n-dimethylamino)ethylthio-sar]-4-(gammahydroxymethylleucine)c- Yclosporine App 20100173837 - Hopkins; Samuel Earl	2010-07-08
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection Grant 7,718,767 - Fliri , et al. May 18, 2	2010-05-18
Arylalkyl and Heteroarylalkyl Derivaties of Cyclosporine a for the Treatment and Prevention of Viral Infection App 20090298751 - Houck; David Renwick ; et al.	2009-12-03
Cyclic peptides Grant 7,576,057 - Scribner , et al. August 18, 2	2009-08-18
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection Grant 7,196,161 - Fliri , et al. March 27, 2	2007-03-27
Method of separating compound(s) from mixture(s) Grant 6,736,975 - Gandelheid , et al. May 18, 2	2004-05-18

Company Registrations

NCAGE Code	33SU8	SCYNEXIS, INC.
CAGE Code	33SU8	SCYNEXIS, INC.
S.A.M. Registration	33SU8 [1073530]	SCYNEXIS, INC.
SEC	0001178253	SCYNEXIS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.